Skip to main content

Table 1 Basic Characteristics of four passages patients

From: Epidemiological and clinical based study on four passages of COVID-19 patients: intervention at asymptomatic period contributes to early recovery

 

Numbers (%)

 

Passage 1 (n = 1)

Passage 2 (n = 8)

Passage 3 (n = 23)

Passage 4 (n = 46)

p values

Age

Median

48.00

51.50

48.00

44.00

0.19

Gender

 Female

0

4 (50.00)

10 (43.48)

20 (43.47)

0.40

 Male

1

4 (50.00)

13 (56.52)

26 (56.53)

Symptoms

 Fever

1

7 (87.50)

16 (69.57)

26 (56.52)

0.19

 Cough

1

8 (100.00)

18 (78.26)

38 (82.61)

0.36

 Fatigue

1

8 (100.00)

23 (100.00)

44 (95.65)

0.50

 Headache

0

1 (12.50)

2 (8.70)

1 (2.17)

0.32

 Anorexia

0

1 (12.50)

4 (17.39)

12 (26.08)

0.56

 Diarrhear

0

0 (0.00)

0 (0.00)

0 (0.00)

 

 Nasal congestion

0

0 (0.00)

1 (4.35)

0 (0.00)

0.30

 Pharyngalgia

1

4 (50.00)

10 (43.48)

7 (15.22)

0.01

 Lymphadenopathy

0

0 (0.00)

0 (0.00)

0 (0.00)

 

 Myalgia

1

1 (12.50)

1 (4.35)

7 (15.22)

0.41

 Dyspnea

0

2 (25.00)

1 (4.35)

0 (0.00)

0.003

 Vomit

0

0 (0.00)

1 (4.35)

1 (2.17)

0.77

 Abdomin pain

0

1 (12.50)

1 (4.35)

0 (0.00)

0.10

Comorbidities

 Hypertension

0

4 (50.00)

6 (26.09)

9 (19.57)

0.18

 Diabetes

0

4 (25.00)

3 (0.00)

1 (0.00)

< 0.001

 Tuberculosis

0

3 (37.50)

1 (4.35)

3 (6.52)

0.01

 Hepatitis B

0

0 (0.00)

1 (4.35)

2 (4.35)

0.83

 Cardiovascular disease

0

0 (0.00)

1 (4.35)

0 (0.00)

0.30

 COPD

0

1 (12.50)

0 (0.00)

0 (0.00)

0.01

 Malignancy

0

0 (0.00)

0 (0.00)

0 (0.00)

 

 Chronic kidney Disease

0

0 (0.00)

0 (0.00)

0 (0.00)

 

 Chronic liver disease

0

0 (0.00)

0 (0.00)

0 (0.00)

 

 HIV

0

0 (0.00)

0 (0.00)

0 (0.00)

 

Medium incubation days

9.00

7.00 (2–12)

8.00 (4–13)

10.00 (7–15)

0.005

  1. P values indicate differences among Passage 2, Passage 3 and Passage 4 patients. P < 0.05 was considered statistically significant. The comparisons of the clinical characteristics, excluding age and incubation days, were performed by χ2 test. a The comparison of age and the comparison of incubation days among different groups was performed by one-way ANOVA with Bonferroni’s post-test